F2RL1 and congenital bilateral aplasia of vas deferens from CFTR mutation: To design a suitable TDDS for the treatment of CAVD, we determined that PAR2 is highly expressed in osteogenically differentiated VICs, and synthesized a PAR2-ligand functionalized magnetic response nanocarrier to deliver XCT790 to the calcified aortic valves.